MapLight Therapeutics, Inc. (MPLT) Earnings History
Annual and quarterly earnings data from 2022 to 2024
Loading earnings history...
MPLT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MPLT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
Download Data
Export MPLT earnings history in CSV or JSON format
Free sign-in required to download data
MapLight Therapeutics, Inc. (MPLT) Earnings Overview
As of May 15, 2026, MapLight Therapeutics, Inc. (MPLT) reported trailing twelve-month net income of -$103M, reflecting -39.6% year-over-year growth. The company earned $-2.48 per diluted share over the past four quarters.
Looking at the long-term picture, MPLT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$30M in fiscal 2022.
MapLight Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ACNB ($37M net income, 21.7% margin), PTGX (-$115M net income, -282.8% margin), TERN (-$96M net income), MPLT has comparable earnings metrics. Compare MPLT vs ACNB →
MPLT Earnings vs Peers
Earnings metrics vs comparable public companies
MPLT Historical Earnings Data (2022–2024)
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$78M | -39.3% | -$83M | $-1.87 | - | - |
| 2023 | -$56M | -85.6% | -$57M | $-1.34 | - | - |
| 2022 | -$30M | - | -$31M | $-0.72 | - | - |
See MPLT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MPLT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare with Peers
Compare business quality, growth, and profitability against top sector peers.
Start ComparisonMPLT — Frequently Asked Questions
Quick answers to the most common questions about buying MPLT stock.
Is MPLT growing earnings?
MPLT EPS fell to $-2.48, with earnings declining -39.6%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-103M.
What are MPLT's profit margins?
MapLight Therapeutics, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are MPLT's earnings?
MPLT earnings data spans 2022-2024. The declining earnings trend is -39.6% YoY. Historical data enables comparison across business cycles.